Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 75 entries
View as:

A Study of the Prevalence of Headache in Epileptic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00277368 Org: User:
Start: 07/31/05 End: 03/31/06 Due: 03/31/07

Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01816503 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01060150 Org: User:
Start: 07/31/08 End: 04/30/10 Due: 04/30/11

Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT01060202 Org: User:
Start: 11/30/09 End: 07/31/11 Due: 07/31/12

ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00246168 Org: User:
Start: - End: 06/30/05 Due: 06/30/06

A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01294722 Org: User:
Start: 12/31/11 End: 08/31/12 Due: 08/31/13

An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01006356 Org: User:
Start: 10/31/08 End: 08/31/09 Due: 08/31/10

Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT01021592 Org: User:
Start: 03/31/07 End: 07/31/08 Due: 07/31/09

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Phase: N/A Priority: Normal
NCT ID: NCT01624649 Org: User:
Start: 02/29/12 End: 04/30/14 Due: 04/30/15

A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00634543 Org: User:
Start: 12/31/06 End: 10/31/08 Due: 10/31/09

A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00642837 Org: User:
Start: 09/30/07 End: 05/31/08 Due: 05/31/09

Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT00797017 Org: User:
Start: 05/31/08 End: 12/31/08 Due: 12/31/09

Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants

Phase: N/A Priority: Normal
NCT ID: NCT00761605 Org: User:
Start: 04/30/08 End: 10/31/10 Due: 10/31/11

A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01030094 Org: User:
Start: 02/28/07 End: 04/30/09 Due: 04/30/10

PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00761189 Org: User:
Start: 02/29/08 End: 07/31/10 Due: 07/31/11

Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid

Phase: N/A Priority: Normal
NCT ID: NCT01532895 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Phase: N/A Priority: Normal
NCT ID: NCT04852692 Org: User:
Start: 06/21/21 End: 08/06/21 Due: 08/06/22

Fentanyl Matrix in Lung Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT01060137 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

Phase: N/A Priority: Normal
NCT ID: NCT01060462 Org: User:
Start: 08/31/08 End: 02/28/09 Due: 02/28/10

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence

Phase: N/A Priority: Normal
NCT ID: NCT01741844 Org: User:
Start: 09/30/12 End: 07/31/14 Due: 07/31/15

Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT01005628 Org: User:
Start: 06/30/06 End: 03/31/12 Due: 03/31/13

Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

Phase: N/A Priority: Normal
NCT ID: NCT03942120 Org: User:
Start: 04/08/19 End: 01/14/22 Due: 01/14/23

A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01819818 Org: User:
Start: 05/23/11 End: 11/29/19 Due: 11/29/20

Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02229344 Org: User:
Start: 07/01/14 End: 02/22/22 Due: 02/22/23

A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04214691 Org: User:
Start: 12/17/19 End: 02/07/20 Due: 02/07/21